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Introduction: Recent studies have demonstrated the feasibility of real-time ultrasound guidance during percutaneous
dilatational tracheostomy, including in patients with risk factors such as coagulopathy, cervical spine immobilization
and morbid obesity. Use of real-time ultrasound guidance has been shown to improve the technical accuracy of
percutaneous dilatational tracheostomy; however, it is unclear if there is an associated reduction in complications.
Our objective was to determine whether the peri-procedural use of real-time ultrasound guidance is associated with
a reduction in complications of percutaneous dilatational tracheostomy using a propensity score analysis.
Methods: This study reviewed all percutaneous dilatational tracheostomies performed in an 8-year period in a
neurocritical care unit. Percutaneous dilatational tracheostomies were typically performed by trainees under guidance
of the attending intensivist. Bronchoscopic guidance was used for all procedures with addition of real-time ultrasound
guidance at the discretion of the attending physician. Real-time ultrasound guidance was used to guide endotracheal
tube withdrawal, guide tracheal puncture, identify guidewire entry level and confirm bilateral lung sliding. The primary
outcome was a composite of previously defined complications including (among others) bleeding, infection, loss of
airway, inability to complete procedure, need for revision, granuloma and early dislodgement. Propensity score analysis
was used to ensure that the relationship of not using real-time ultrasound guidance with the probability of an adverse
outcome was examined within groups of patients having similar covariate profiles. Covariates included were age,
gender, body mass index, diagnosis, Acute Physiology and Chronic Health Evaluation II score, timing of tracheostomy,
positive end-expiratory pressure and presence of risk factors including coagulopathy, cervical spine immobilization
and prior tracheostomy.
Results: A total of 200 patients underwent percutaneous dilatational tracheostomy during the specified period, and
107 received real-time ultrasound guidance. Risk factors for percutaneous dilatational tracheostomy were present in 63
(32%). There were nine complications in the group without real-time ultrasound guidance: bleeding (n = 4), need for
revision related to inability to ventilate or dislodgement (n = 3) and symptomatic granuloma (n = 2). There was one
complication in the real-time ultrasound guidance group (early dislodgement). The odds of having an adverse outcome
for patients receiving real-time ultrasound guidance were significantly lower (odds ratio = 0.08; 95% confidence interval,
0.009 to 0.811; P = 0.032) than for those receiving a standard technique while holding the propensity score quartile fixed.
Conclusions: The use of real-time ultrasound guidance during percutaneous dilatational tracheostomy was associated
with a significant reduction in procedure-related complications.* Correspondence: vrajajee@yahoo.com
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Percutaneous dilatational tracheostomy (PDT) is a well
established and widely utilized technique in the ICU,
with a safety profile that compares favorably to surgical
tracheostomy [1-3]. The reported incidence of significant
complications for PDT is about 1 to 10%, including both
short-term (such as bleeding, loss of airway and infection)
and long-term (tracheal stenosis, tracheomalacia, tracheo-
cutaneous fistula, and so forth) complications [1-3]. Many
of these complications are potentially preventable and
may be related to technical and procedural factors.
Attention to the level of placement may have an impact
on the risk of tracheal stenosis, trachea-innominate fistula
and dislodgment [4-8]. Selection of the appropriate tube
size and puncture site may decrease the risk of early
dislodgement [9]. Avoidance of vascular structures may
decrease the risk of bleeding [10-13]. Accurate assessment
of endotracheal tube (ETT) tip position may decrease the
risk of airway loss [14-16]. These procedural considerations
may be particularly relevant in patients with high-risk
factors, which may increase the technical difficulty of the
procedure and the risk of complications. These high-risk
factors include coagulopathy, morbid obesity, cervical
spine immobilization (CSI), repeat tracheostomy and the
ongoing need for high levels of respiratory support [17].
While bronchoscopic guidance is routinely used during
PDT, bedside ultrasound has, more recently, received
attention as a potentially useful tool to improve the safety
of PDT. Pre-procedural assessment with ultrasound was
described several years ago, as was the use of ultrasound
during the procedure to facilitate tracheal puncture at the
appropriate level, without real-time visualization of needle
passage [7,9-12,18-20]. Our group has previously demon-
strated the feasibility of real-time ultrasound guidance
(RUSG) during PDT, including in patients with high-risk
factors, with real-time visualization of tracheal puncture
in the axial plane [21]. Several investigators have since
demonstrated that RUSG-guided PDT (RUSG-PDT) is
feasible and potentially useful [22-29]. The value of
RUSG may be greatest in patients with high-risk factors,
such as CSI and morbid obesity [19,20,23]. Two recent
randomized controlled trials have demonstrated that the
use of RUSG may significantly improve technical success
and first-pass success rates [27,28]. While providing a
compelling argument for the incorporation of RUSG into
routine practice, these clinical trials were either not
powered to detect a difference in complication rates or
excluded patients with high-risk factors such as coagulopa-
thy and CSI, who may be most likely to benefit from RUSG.
No study, to our knowledge, has specifically evaluated the
impact of RUSG on complication rates in a population with
a significant proportion of high-risk factors.
Our objective therefore was to review all PDTs performed
at our institution over an 8-year period, and determine theimpact of RUSG on the risk of procedure-related complica-
tions. Given that this study was observational in nature and
did not feature a randomized design, we employed a
propensity score analysis to control for differences in risk
factors and baseline variables which may have influenced
the selection of a particular technique.
Materials and methods
Approval of the University of Michigan Institutional
Review Board was obtained for this study (HUM00062598).
A waiver of informed consent was granted as the study
involved analysis of data from an existing dataset and
medical records. Data on all tracheostomies performed in
the neurointensive care unit at the University of Michigan
is prospectively entered into a database for the purposes of
quality-assurance and ongoing review of complications. We
reviewed information from the database, supplemented by
information from the medical records, of all patients who
underwent PDT in the neurointensive care unit of the
University of Michigan between 2005 and 2013. Patients
who underwent surgical tracheostomy were excluded. We
confined our analysis to the neuroscience ICU because
RUSG is predominantly used in the neuro-ICU at our insti-
tution. Restricting the analysis to neuro-ICU patients
provided the additional benefit of relative homogeneity
in the patient population, the types of illnesses and
the individuals performing the procedures. Patients
with less than 30 days of follow-up were excluded.
Outcome of interest
The primary outcome of interest was the occurrence of a
significant peri-procedural complication of PDT. The
specific complications included in the composite outcome
measure included both short- and long-term adverse
events. Short-term complications included loss of airway
during procedure, cardiac arrest during the procedure,
bleeding requiring intervention, stomal or mediastinal
infection, posterior wall injury, pneumothorax, pneumo-
mediastinum, nerve injury, sustained hypoxia (>5 minutes)
during the procedure, false passage of tube, inability to
complete procedure, conversion to surgical tracheostomy,
need for revision of tracheostomy, tracheal granuloma and
early dislodgement (within 7 days). Delayed complications
included tracheomalacia, tracheal stenosis, tracheoinnomi-
nate fistula and tracheo-esophageal or tracheo-cutaneous
fistula/delayed closure. Bleeding requiring intervention
included the need for any transfusion of blood products,
electrocautery or other surgical hemostasis, revision of
tracheostomy and discontinuation of medically necessary
antithrombotic or antiplatelet therapy.
Risk factors and other covariates
The medical record was reviewed for the presence of
high-risk factors present at the time of PDT, which were
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included the presence of coagulopathy, CSI, repeat
tracheostomy, presence of thyroid mass over the trachea
and inability to palpate the cricoid cartilage or visualize
the first tracheal ring on ultrasound. Morbid obesity and
high positive end-expiratory pressure (PEEP) requirement
were also considered high risk factors, with body mass
index (BMI) and PEEP at the time of procedure included
as continuous variables in the propensity score analysis.
Other variables in the propensity score analysis included
age, gender, days from admission to tracheostomy, primary
diagnosis category and Acute Physiology and Chronic
Health Evaluation (APACHE) II score. The primary
diagnosis categories were traumatic brain injury, sub-
arachnoid hemorrhage, intracerebral hemorrhage, acute
ischemic stroke, spinal cord injury, status epilepticus,
brain tumor, and other. Coagulopathy was defined as the
presence of a laboratory abnormality suggestive of impair-
ment in coagulation and/or the use of therapeutic anticoa-
gulation or intensive antiplatelet therapy. Laboratory
abnormalities indicative of coagulopathy were: platelet
count <50,000/uL, International Normalized Ratio >1.7,
partial thromboplastin time (PTT) >1.5 times the normal
value and/or fibrinogen <100 mg/dL. The abnormal
laboratory result had to be present on the day of the
procedure, without pre-procedural correction, to meet
the definition of coagulopathy. Patients on unfractionated
heparin and warfarin were considered coagulopathic only
if the appropriate PTT and International Normalized Ratio
criteria were met, or, in the case of unfractionated heparin,
if the infusion was restarted and a therapeutic PTT
recorded within 12 hours of completion of PDT.
Anticoagulant agents included in the definition of
coagulopathy, regardless of laboratory abnormality,
included therapeutic use of low molecular weight heparin,
direct thrombin inhibitors and direct Xa inhibitors.
Anticoagulation with these agents, as well as with
unfractionated heparin and warfarin, was typically discon-
tinued or reversed the morning of the procedure, and
had to be restarted within 12 hours of PDT to meet
the definition of coagulopathy. Intensive antiplatelet
therapy, defined as combination therapy with aspirin
and clopidogrel, was not held or reversed for PDT.
Timing and selection of technique
Timing of tracheostomy was decided on a case-by-case
basis, with tracheostomy typically performed when the
attending intensivist determined that the patient would
likely require airway protection or mechanical ventilation
for 3 weeks or longer. Selection of technique, including
use of RUSG-PDT versus standard PDT (S-PDT), was at
the discretion of the intensivist performing the procedure.
Several intensivists staffing the unit during this period
were not trained in performance of, or not activelyperforming, PDTs and therefore typically referred patients
to the otolaryngology service for surgical tracheostomy.
The baseline characteristics of patients referred for surgical
tracheostomy (age, gender, days from admission to trache-
ostomy, BMI, PEEP, primary diagnosis category, APACHE
II score and presence of the high-risk factors listed above)
were compared to those of the PDT group to assess for a
possible selection bias. All PDTs were typically performed
by fellows or residents directly supervised by attending
intensivists with at least 2 years experience with PDT and
at least 1 year experience with RUSG, when used. All inten-
sivists actively performing PDT during this period were
trained by one of the authors (VR) in performance of
RUSG-PDT. Bronchoscopy was utilized for all PDTs. The
Ciaglia Blue Rhino® PDT kit (Cook Medical Inc, Blooming-
ton, IN) was used for all patients. Tracheostomy tubes used
included the Shiley™-DCT (sizes 6 and 8), Shiley™-XLT
(sizes 6 and 7) (Covidien, Dublin, Ireland) and the Cook
VersaTube™ (sizes 8 and 9) (Cook Medical Inc, Blooming-
ton, IN). Selection of tracheostomy size and length was at
the discretion of the intensivist performing the procedure,
with selection typically based on patient height, gender,
body habitus, neck anatomy and measurement of pretra-
cheal soft tissue thickness when RUSG was used.
Standard technique
A propofol infusion was typically utilized for sedation along
with fentanyl for analgesia and a nondepolarizing agent, typ-
ically vecuronium, for neuromuscular blockade. The patient
was positioned with the head in extension except when CSI
was present, when the head was maintained in the neutral
position. The ETT was withdrawn using bronchoscopic
guidance and/or direct laryngoscopy until the tip was ap-
proximately at the level of the cricoid cartilage. An incision
was first made following administration of local anesthetic
(1% lidocaine with epinephrine), blunt dissection with a
hemostat performed, then tracheal puncture performed
under bronchoscopic guidance. The intent in all cases was to
puncture the trachea between the first and the fourth rings
in the anterior quadrant. The guidewire was then inserted
and an initial stoma created with a 14 Fr dilator. This was
followed by passage of the single-stage Ciaglia Blue Rhino®
dilator over the guide catheter and the guidewire. The
tracheostomy tube fitted on the appropriate loading dilator
was then introduced into the trachea over the guide catheter
and the guidewire and secured with sutures. Confirmation of
tube position was with bronchoscopy and chest radiography.
Technique of real-time ultrasound guided
percutaneous dilatational tracheostomy
A Sonosite M-Turbo® (SonoSite Inc., Bothell, WA, USA)
point-of-care ultrasound machine was used for all
RUSG-PDTs, with either a 13–6 MHz or 10–5 MHz
linear array probe within a sterile sheath. The RUSG-PDT
Figure 2 Anterior tracheal wall puncture on ultrasound. Axial view
of the trachea demonstrating the visualized part of the needle at
the anterior tracheal wall; Th-Is, thyroid Isthmus; T-R, tracheal Ring.
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ways. First, pre-procedural assessment of anatomy was
performed with ultrasound, following appropriate patient
positioning, to delineate vascular structures, pretracheal
tissue thickness and intended site of puncture. Where a
vascular structure was identified in the tracheostomy field,
the patient was not automatically assigned to surgical
tracheostomy. Instead, RUSG was used to avoid the vascu-
lar structure during tracheal puncture. Withdrawal of the
ETT was performed under direct ultrasound guidance,
using the technique previously described [16], until the
tip was directly visualized under the cricoid cartilage
(Figure 1). Where RUSG was used to withdraw the ETT,
concurrent bronchoscopy/direct laryngoscopy was not per-
formed while the tube was being withdrawn. Tracheal
puncture was performed prior to incision of the neck, with
the intent to enter the trachea between the first and fourth
rings under RUSG. Selection of axial versus longitudinal
(out-of-plane versus in-plane) view during puncture was at
the discretion of the intensivist performing the procedure,
although the axial view was utilized in most instances to
facilitate puncture in the midline. The needle was then
tracked from the skin to the anterior tracheal wall
(Figure 2). Once the needle tip was directly visualized
penetrating the anterior tracheal wall, the guidewire was
introduced through the needle. Guidewire entry at the
desired tracheal ring level and entry in the anterior
quadrant were then confirmed in both the axial (Figure 3)
and longitudinal (Figure 4) planes using ultrasound before
skin incision and blunt dissection. Bronchoscopy was not
utilized during RUSG tracheal puncture; instead, the bron-
choscope was introduced following guidewire insertion to
confirm intra-luminal passage. Following placement of the
tracheostomy tube, lung sliding was assessed bilaterallyFigure 1 Endotracheal tube position on ultrasound. Longitudinal view
of the trachea, demonstrating final positioning of the endotracheal
tube (ETT) tip prior to tracheal puncture. CR, cricoid cartilage in cross
section; T1, first tracheal ring in cross section; T2, second tracheal ring
in cross section; T3, third tracheal ring in cross section.over the anterior chest to confirm tube placement (in
addition to bronchoscopic and radiographic confirmation)
and evaluated for atelectasis (from blood or mucus occlu-
sion of the bronchial passages) or pneumothorax [30].
Additional steps incorporating RUSG were utilized in pa-
tients with high-risk factors. Pre-procedural measurement
of pre-tracheal tissue thickness with ultrasound was per-
formed in patients with morbid obesity or an unusually
thick neck to aid selection of tracheostomy tube length
and size, as previously described [9]. The skin to second
tracheal ring thickness was measured using ultrasound
with the head in the neutral position. A tracheostomy tube
with distance from flange to cuff (proximal plus radial
length) at least 1.5 cm greater than this distance was then
selected (for example, an extended proximal length
Shiley™ 60XLT tube with proximal plus radial length of
6.1 cm versus a Shiley™ DCT-6 tube with proximal plusFigure 3 Confirmation of guidewire position (axial). Axial view of
the trachea following guidewire (GW) passage, seen entering the
tracheal lumen to the right of the midline. Th-L, thyroid lobe.
Figure 4 Confirmation of guidewire position (longitudinal).
Longitudinal view of the trachea following guidewire (GW) passage,
seen entering the trachea between the first and second tracheal
rings. CR, cricoid cartilage in cross section; ETT, endotracheal tube
tip; T1, first tracheal ring in cross section; T2, second tracheal ring in
cross section.
Figure 5 Visualization and avoidance of vascular structures.
(A) Longitudinal view of the trachea with duplex imaging. A
paramedian artery is seen, likely the thyroid ima. (B) Axial view
of the trachea during puncture with duplex imaging (same patient
as in (A)). The needle tip is directed to the anterior tracheal wall
under real-time duplex guidance while avoiding the previously
seen paramedian artery (likely the thyroid ima). Art, artery; Ne,
needle tip; Th-Is, thyroid isthmus.
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tomy, RUSG was utilized to guide puncture at the site of
prior tracheostomy to minimize additional scar tissue. In
patients with coagulopathy, specific care was taken to
avoid the following vascular structures during puncture:
inferior thyroid veins, arterial branches along the isthmus
and trachea (Figure 5A,B), the thyroid isthmus itself and
any thyroid mass lesions. Axial and longitudinal views on
ultrasound, in conjunction with varying angles of entry
and levels of puncture, were utilized to guide the needle
past these structures while attempting to enter the trachea
between the first and fourth rings. The inferior thyroid
veins and thyroid isthmus were not routinely avoided in
patients without coagulopathy, however, and were
punctured if necessary to obtain entry at the desired
level. Of note, ultrasound-guided withdrawal of the ETT
(versus withdrawal under bronchoscopic or laryngoscopic
guidance) and measurement of pre-tracheal soft tissue
thickness were performed variably at the attending
physician’s discretion, while the other steps incorporating
RUSG described above were performed for all patients
undergoing RUSG-PDT.
Statistical analysis
Descriptive statistics computed for the variables of interest
included frequencies for categorical variables and median
with interquartile range (IQR) for continuous variables.
Bivariate associations of categorical variables with the
outcomes of interest were tested using the Chi-square test
or Fisher’s exact test, as appropriate. Bivariate associations
of continuous variables with the binary outcomes of
interest were assessed using the Mann–Whitney U test.
Propensity score analysis was used to ensure that the
relationship of not using ultrasound guidance with theprobability of an adverse outcome was examined within
groups of patients having similar covariate profiles.
Propensity score analysis is useful in estimating the effect
of an intervention (RUSG) in a retrospective observational
study while adjusting for the covariates, or baseline
variables, that predict receiving the intervention [31,32].
Propensity score analysis decreases the bias due to con-
founding variables that can occur when the intervention
effect is estimated by simply comparing outcomes among
patients receiving the intervention to those that did not.
Logistic regression modeling was first used to predict the
probability of receiving RUSG for each patient (that
is, the propensity score) as a function of several potential
confounding variables: age, gender, BMI, days from
admission to tracheostomy, primary diagnosis category,
APACHE II score, PEEP at time of procedure, presence
of coagulopathy, presence of CSI, prior tracheostomy,
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palpate the cricoid cartilage or visualize the first tracheal
ring on ultrasound. The predicted probabilities (propensity
scores) were then recoded into quartiles, and a new factor
was computed indicating the quartile to which each patient
was assigned based on their propensity score. A logistic re-
gression model was then fitted to the adverse outcome
indicator (complication of tracheostomy), including the indi-
cator of receiving RUSG and the propensity score quartile as
independent variables. Inclusion of the propensity score
quartile in this logistic regression model evaluating the pre-
dictive value of RUSG usage for occurrence of complications
therefore helps account for the differential probability of re-
ceiving the intervention (RUSG) based on the covariate pro-
file. The threshold for statistical significance was P < 0.05. All
statistical analysis was performed using IBM SPSS Statistics
for Macintosh, Version 22.0 (Armonk, NY: IBM Corp).
Results
A total of 384 tracheostomies were performed in the
neuro-ICU of the University of Michigan in the study
period. Of these, 232 were PDT while the remainder
were surgical. No single baseline variable demonstrated
a statistically significant difference between patients
undergoing PDT and surgical tracheostomy. Thirty-two
patients who underwent PDT were excluded because ofTable 1 Distribution of variables in patients undergoing RUSG
Variable S-PDT (n = 93)
Age in years (median (IQR)) 58 (21)
Female gender (n (%)) 39 (42%)
Body mass index in kg/m2 (median (IQR)) 27 (6)
Diagnosis (n (%))
-Subarachnoid hemorrhage 27 (29%)
-Traumatic brain injury 15 (16%)
-Intracerebral hemorrhage 15 (16%)
-Acute ischemic stroke 11 (12%)
-Neuromuscular respiratory failure 6 (6%)
-Spinal cord injury 5 (5%)
-Status epilepticus 8 (9%)
-Other 3 (3%)
-Brain tumor 3 (3%)
Days from admission to tracheostomy (median (IQR)) 5 (6)
APACHE II score (median (IQR)) 18 (7)
PEEP at time of procedure in cmH2O (median (IQR)) 5 (0)
Cervical spine immobilized (n (%)) 10 (11%)
Coagulopathy (n (%)) 12 (13%)
Repeat tracheostomy (n (%)) 0 (0%)
Distribution of variables in patients undergoing real-time ultrasound guided percut
dilatational tracheostomy (S-PDT), with P value from multivariate analysis represent
ultrasound guidance. APACHE, Acute Physiology and Chronic Health Evaluation; IQRnon-availability of at least 30 days of follow-up. Of note,
none of these thirty-two excluded patients suffered a
complication of tracheostomy during the limited period
of follow-up available. Of 200 patients included in the
analysis, 107 (53.5%) underwent RUSG-PDT while 93
(46.5%) underwent S-PDT. The distribution of variables
in patients undergoing RUSG-PDT and S-PDT is shown
in Table 1. A high-risk factor was present in 63 of 200
patients (31.5%): coagulopathy in 26 (13%), CSI in 25
(12.5%), PEEP requirement >10 cmH2O in 14 (7%),
BMI >40 in 8 (4%) and prior tracheostomy in 2 (1%).
The median duration of follow-up was 206 (IQR 653)
days, median 197 (IQR 739) days in the S-PDT group
and median 222 (IQR 551) days in the RUSG-PDT group
(P = 0.31). No patient in either group was assigned to
surgical tracheostomy following pre-procedural clinical/
anatomical (in both groups) or pre-procedural ultrasound
(in the RUSG group) examination. Inability to palpate the
cricoid cartilage or visualize the first tracheal ring on
ultrasound (or other unfavorable anatomic feature) was
not specifically documented in any patient. Selection of
tracheal tube length on the basis of sonographic measure-
ment of pre-tracheal tissue thickness was documented
in 28 patients (27% of the RUSG-PDT group), with
an extended-length tube selected in 20 (71%) of these
patients.-PDT and S-PDT
RUSG-PDT (n = 107) P value from multivariate analysis
54 (28) 0.11
56 (52%) 0.29
27 (8) 0.55
25 (23%) 0.14
14 (13%) 0.66
20 (19%) 0.24
15 (14%) 0.28
10 (9%) 0.30
8 (7%) 0.33
5 (5%) 0.72
7 (7%) 0.46
3 (3%) 0.99
6 (6) 0.18
19 (10) 0.19
5 (3) 0.42
15 (14%) 0.44
14 (13%) 0.79
2 (2%) 0.99
aneous dilatational tracheostomy (RUSG-PDT) and standard percutaneous
ing the P value from a logistic regression model predicting use of real-time
, interquartile range; PEEP, positive end-expiratory pressure.
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A significant complication was present in 10 of 200
patients (5%), and the list of significant complications
is shown in Table 2. Nine of 93 patients (10%) in the
S-PDT group and 1/103 (1%) patients in the RUSG group
had a complication (P = 0.007). The single complication in
the RUSG-PDT group was an early dislodgment (on day 6)
in an agitated patient with cirrhosis and hepatic
encephalopathy and previous tracheostomy. In the
subgroup of patients without high-risk factors (n = 137),
5/67 (7%) patients in the S-PDT group and 0 of 70 (0%) in
the RUSG-PDT group suffered a complication (P = 0.026).
In the subgroup of patients with high-risk factors (n = 63),
4/26 (15%) patients in the S-PDT group versus 1/37
(3%) patients in the RUSG-PDT group suffered a
complication (P = 0.15). Among 26 patients with coagu-
lopathy, 4/12 (33%) who underwent S-PDT versus 0/14
who underwent RUSG-PDT suffered bleeding requiring
intervention (P = 0.033).
Propensity score analysis
No variable attained statistical significance in the logistic
regression model constructed to predict the probability
of receiving RUSG (Table 1), suggesting that the two
groups of patients were fairly well balanced in terms of
covariate profiles. In the logistic regression model fitted
to the adverse outcome indicator (occurrence of a
tracheostomy complication) including the indicator of
receiving RUSG and the propensity score quartile, the
odds of an adverse outcome for patients who under-
went RUSG was found to be significantly lower (odds
ratio = 0.087; 95% confidence interval, 0.009 to 0.811;
Table 3) than among patients who received the standard
technique, while holding the propensity score quartile
fixed. The uncertainty associated with the estimated odds
ratio reflects the small sample size and the small number
of adverse outcomes (10/200). Despite these limitations,
the coefficient for ultrasound receipt was still significantly
different from zero (P = 0.032) when controlling for
propensity score quartile.
Discussion
Our study examined the impact of RUSG on the occur-
rence of complications following PDT, using propensity
score analysis to account for any disparities in baseline
variables that may have influenced selection of a particu-
lar technique. The use of RUSG was associated with a
statistically significant 10-fold reduction in complications,
while holding the propensity score quartile fixed. While
several studies have demonstrated the feasibility and
technical advantages of RUSG, our study is significant
in, to our knowledge, being the first to demonstrate a
clinically meaningful reduction in complications. Table 2,
which describes the 10 complications seen in this study,may be particularly useful in demonstrating the value of
RUSG. of the nine complications seen in the S-PDT
group, at least seven had a specific technical factor identi-
fied which, plausibly, may have resulted in, or contributed
to, the complication. In all these cases, the use of RUSG
may have minimized the impact of these risk factors. This
is particularly noticeable in coagulopathic patients under-
going PDT; four of 12 (33%) coagulopathic patients in the
S-PDT group versus none of 14 coagulopathic patients in
the RUSG-PDT group suffered bleeding requiring inter-
vention (P = 0.033). Three of the four coagulopathic pa-
tients in the S-PDT group who suffered bleeding had a
focal point of bleeding identified, suggesting a vascu-
lar source that might, potentially, have been avoided
with RUSG. Figure 5 illustrates how a paramedian
artery (likely the thyroid ima in the figure) identified
on ultrasound can be avoided using real-time guid-
ance. The other potentially important technical fac-
tor observed was low tracheostomy tube placement
(below the fourth tracheal ring) seen in one patient
who died following a trachea-innominate fistula and
three others requiring revision of tracheostomy. Low
placement has been identified as a possible risk factor for
trachea-innominate fistula [4,5]. Also, it is possible that the
longer segment of the tracheal tube within pre-tracheal tis-
sue in patients with too low a stoma, which may result from
excessive caudal angulation of the needle following skin
puncture, may result in sub-optimal positioning of the
distal segment of the tube within the trachea, increasing
the risk of dislodgment and cuff leaks. Autopsy studies
have demonstrated that sub-optimal level of the tube may
occur despite the use of bronchoscopic guidance [7].
While our study was unable to determine the rela-
tive technical success of PDT (level of placement, pas-
sage in midline) in the RUSG-PDT and S-PDT groups
because of the limitations of retrospective review of
procedural documentation, two recent randomized
controlled trials have demonstrated that incorporation
of RUSG improves the technical success of PDT
[27,28]. Rudas and colleagues demonstrated that the
use of RUSG was more likely to result in a successful
first pass (87% first pass success versus 58%; P = 0.028)
as well as a puncture closer to the midline (mean
deviation from midline 15 ± 3 versus 35 ± 5 degrees;
P = 0.001) [27]. Yavuz and colleagues demonstrated
that the use of RUSG resulted in significantly fewer
patients requiring multiple attempts (4% versus 14%;
P = 0.003), while slightly extending the duration of the
procedure (24 versus 19 minutes, P = 0.001) [28]. Of
note, both studies reported a trend toward lower com-
plication rates with RUSG: 22% versus 37% (P = 0.24)
in the Rudas study, which was not powered to detect
a difference in complication rates, and 8% versus
15% (P = 0.054) in the Yavuz study, a near halving
Table 2 Complications of percutaneous dilatational tracheostomy
Patient
number
RUSG
used
High-risk factor
present
Nature of
complication
Days from
procedure
Details Technical/procedural issue identified
1 N None Bleeding requiring intervention,
inability to complete procedure
0 Large neck hematoma during procedure,
surgical tracheostomy and hemostatsis
performed urgently in OR
Laceration of arterial branch along superior
border of isthmus
2 N Coagulopathy: dual
antiplateley therapy
Bleeding requiring intervention 1 Copious persistent bleeding from stoma,
requiring platelet transfusion and cessation
of dual antiplatelet therapy
Vascular injury likely, specific source
not identified
3 N None Tracheal granuloma 13 Inability to perform routine tube change at
bedside, fiberoptic evaluation revealed a
large tracheal granuloma causing luminal
stenosis. Soft tracheal tube introduced
over fiberoptic scope
None
4 N None Early dislodgment, need for
surgical revision
5 Tracheal tube dislodged, inability to replace
at bedside. Surgical revision required, initial
stoma noted to be below 6th tracheal ring
Too low placement of tracheal tube
5 N Coagulopathy: from
therapeutic plasma
exchange on
consecutive days.
Bleeding requiring intervention 3 Persistent oozing with large hematoma in
upper left quadrant of stoma. Surgical
hemostasis with Surgicell® Fibrillar®
absorbable hemostats
Vascular injury: focal bleeding identified
at bedside at upper left quadrant of stoma
6 N Coagulopathy: warfarin
for venous thromboembolism
Death, bleeding requiring
intervention
266 Massive bleeding and death from
trachea-innominate fistula
Too low placement of tube on autopsy,
proximity to innominate artery.
7 N Coagulopathy: anticoagulation
for venous thromboembolism
Bleeding requiring intervention 7 Persistent copious oozing during and after
procedure. Anticoagulation reversed; surgical
hemostasis performed in OR on day 7
Vascular injury: focus of bleeding
identified in OR
8 N None Need for revision of tracheostomy 1 Persistent large air leak with loss of >30%
tidal volume. Fiberoptic evaluation and
emergent bedside revision performed
post-procedure day 1
Too low placement: tube seen below
6th tracheal ring with suboptimal
positioning on fiberoptic evaluation
9 N None Need for revision of tracheostomy,
early dislodgment
4 Persistent large (20-25%) cuff leak post-procedure
with dislodgment and inability to ventilate on
day 4, surgical revision in OR
Too low placement of tracheal tube
(below 8th ring) with consequent
poor positioning
10 Y Coagulopathy: end-stage
liver disease, repeat
tracheostomy
Early dislodgment 6 Tube dislodged following agitation and head
shaking with subsequent brief period of hypoxia.
Extended length tube replaced at bedside into
stoma over a bougie.
? Inappropriate selection of tube
length. Sonographic measurement
pre-tracheal tissue thickness not
performed.
Details of complications in the standard percutaneous dilatational tracheostomy and real-time ultrasound guidance (RUSG) percutaneous dilatational tracheostomy groups. N, no; OR, operating room; Y, yes.
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Table 3 Real-time ultrasound guidance as a predictor of
any tracheostomy complications
Variables in the
equation
P value Odds
ratio
95% confidence
interval
Real-time ultrasound guidance 0.032 0.087 0.009-0.811
Propensity score quartile 1 0.891
Propensity score quartile 2 0.716 0.616 0.045-8.402
Propensity score quartile 3 0.884 1.199 0.106-13.601
Propensity score quartile 4 0.900 1.172 0.100-13.753
Constant 0.053 0.109
Logistic regression analysis of propensity score quartiles and use of real-time
ultrasound guidance as predictors of any complications of tracheostomy.
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cance, despite the exclusion of patients with coagulopathy
and CSI. We believe that the findings of these two studies,
in conjunction with the findings of our study, strongly
argue for the incorporation of RUSG into routine practice
when performing PDT, particularly in patients with high-
risk factors and at academic centers where the majority of
procedures may be performed by trainees under supervi-
sion. Ultrasound has the advantage of being a non-invasive
tool with little additional cost, where a point-of-care ultra-
sound machine is otherwise available. In our experience,
trainees become familiar with the relevant sonographic
anatomy relatively quickly. Some authors have suggested,
on the basis of observational studies, that PDT can be
performed safely with RUSG alone, without bronchoscopic
guidance [25,29,33]. The primary arguments favoring the
routine use of bronchoscopy may be greater real-time
control of the airway and the ability to visualize the entire
procedure within the trachea itself, to minimize the risk of
posterior wall injury and false passage.
The primary limitation of our study is its retrospective
nature, although data were primarily obtained from a pro-
spective quality assurance database. Selection of technique
(RUSG-PDT versus S-PDT) was at the discretion of the
attending physician, not through random assignment. The
use of a propensity score analysis, however, is likely to have
mitigated the impact of any confounding through an
imbalance in baseline variables and risk factors. In fact, no
specific variable was seen to independently predict the use
of RUSG in our study. It is possible that inter-operator
variability may have influenced the risk of complications;
however, procedures were performed by a wide variety of
critical care trainees supervised by attending physicians in
both groups, as is typical for most academic/teaching
institutions. As previously mentioned, we were unable to
compare the rates of technical accuracy in the RUSG-PDT
and S-PDT groups because of inconsistency in procedural
documentation, including the observed level of placement
and insertion in the midline. For the same reason, we were
unable to compare the time taken to complete S-PDTversus RUSG-PDT. The relatively large magnitude of re-
duction in complications seen with RUSG may, in part, be
related to two study-specific factors. First, most of the pro-
cedures in this study were performed by trainees under
supervision and, second, a relatively large proportion (32%)
of patients had at least one high-risk factor identified. It is
possible that more experienced operators and selection of
patients without high-risk factors, particularly coagulopa-
thy, may mitigate the risk of complications and therefore
the potential benefit of RUSG. While the absolute number
of high-risk patients in our study (n = 63) was insufficient
for meaningful statistical analysis of the value of RUSG in
this subgroup, it is useful to note that, of 37 patients with
high-risk factors who underwent RUSG-PDT in our study,
none suffered a complication related to the specific risk
factor. The single complication in the RUSG group (early
dislodgment during a period of agitation) was likely
unrelated to the high-risk factors present in that patient (co-
agulopathy and previous tracheostomy). The population in
this study was drawn from the neuro-ICU; therefore, the
generalizability of its findings to patients in general medical/
surgical ICUs is uncertain. In these units, the primary indi-
cation for tracheostomy is more likely to be refractory re-
spiratory failure where gas exchange and hemodynamic
stability may be more influenced by the technique and dur-
ation of the procedure, whereas in our study only 7% of pa-
tients required PEEP > 10 cmH2O at the time of the
procedure. Where acute respiratory failure is a greater con-
cern, the ability to minimize the occlusive effect of the bron-
choscope in the airway, through primary use of RUSG for
critical portions of the procedure such as ETT withdrawal
and initial puncture, may, in fact, be more important.
The minimum duration of follow-up of 30 days may
also have been insufficient to detect differences in the rates
of long-term complications. The median duration of
follow-up was over 6 months in both groups, however, with
no statistically significant difference in median follow-up
period between groups and only one long-term complica-
tion noted in the study (a delayed trachea-innominate
fistula). Finally, the influence of unmeasured confounders
cannot be entirely excluded.
Conclusion
The use of RUSG during PDT was associated with a
significantly lower rate of procedure-related complications
in a propensity score matched analysis.
Key messages
 The use of RUSG during PDT may decrease the
risk of complications.
 RUSG may be particularly useful when performing
PDT in patients with risk factors, such as
coagulopathy.
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